2023-24 RSV Season and Synagis Prior Authorization Ends March 15 For All Regions

Published on

The Texas Health and Human Services Commission (HHSC) will close the 2023-24 respiratory syncytial virus (RSV) season’s Synagis prophylaxis therapy for all regions on March 15, 2024. The season began in various HHS regions between Oct. 2 and Nov. 1, 2023.

HHSC based this decision on the recommendation of the Texas RSV task force and the HHSC Office of the Medical Director (OMD) because of the continued decrease in RSV test positivity in the past two consecutive weeks. HHSC, in collaboration with the RSV task force and OMD, will continue to monitor RSV activities and notify the public about any updates needed to allow access to Synagis prophylaxis treatments.

HHSC does not cover RSV vaccines through pharmacy benefits, and this notice does not impact the vaccination of eligible members through the Texas Vaccine Program.